Similarly, CEA levels can be influenced by malignancies such as colorectal cancer, breast cancer, and non-small-cell lung cancer (NSCLC), as well as benign factors like liver and biliary dysfunction (4, 5). Here, CEACAM5 is linked to breast cancer.